PortalPublikationenClinical value of 2-deoxy-[18F]fluoro-D-glucose positron emi...

Clinical value of 2-deoxy-[18F]fluoro-D-glucose positron emission tomography in patients with cervical spondylotic myelopathy

Standard

Clinical value of 2-deoxy-[18F]fluoro-D-glucose positron emission tomography in patients with cervical spondylotic myelopathy. / Eicker, Sven O; Langen, Karl-Josef; Galldiks, Norbert; Stoffels, Gabriele; Herdmann, Jörg; Steiger, Hans-Jakob; Floeth, Frank W.

in: NEUROSURG FOCUS, Jahrgang 35, Nr. 1, 07.2013, S. E2.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Eicker, SO, Langen, K-J, Galldiks, N, Stoffels, G, Herdmann, J, Steiger, H-J & Floeth, FW 2013, 'Clinical value of 2-deoxy-[18F]fluoro-D-glucose positron emission tomography in patients with cervical spondylotic myelopathy', NEUROSURG FOCUS, Jg. 35, Nr. 1, S. E2. https://doi.org/10.3171/2013.3.FOCUS1379

APA

Eicker, S. O., Langen, K-J., Galldiks, N., Stoffels, G., Herdmann, J., Steiger, H-J., & Floeth, F. W. (2013). Clinical value of 2-deoxy-[18F]fluoro-D-glucose positron emission tomography in patients with cervical spondylotic myelopathy. NEUROSURG FOCUS, 35(1), E2. https://doi.org/10.3171/2013.3.FOCUS1379

Vancouver

Eicker SO, Langen K-J, Galldiks N, Stoffels G, Herdmann J, Steiger H-J et al. Clinical value of 2-deoxy-[18F]fluoro-D-glucose positron emission tomography in patients with cervical spondylotic myelopathy. NEUROSURG FOCUS. 2013 Jul;35(1):E2. https://doi.org/10.3171/2013.3.FOCUS1379

Bibtex

@article{293196bf3b2e497cbe5fd3074f60d9a3,
title = "Clinical value of 2-deoxy-[18F]fluoro-D-glucose positron emission tomography in patients with cervical spondylotic myelopathy",
abstract = "Cervical spondylotic myelopathy (CSM) is one of the most common spinal cord disorders in the elderly. It is usually diagnosed by MRI, but in a significant number of patients the clinical course of CSM does not correlate with the extent of the spinal cord compression. Recent studies have suggested that a distinct metabolic pattern of the cervical cord, as assessed by PET with 2-deoxy-[(18)F]fluoro-D-glucose ((18)F-FDG) may predict a patient's clinical outcome after decompressive surgery for cervical spine stenosis. The authors provide an overview of the recent literature regarding the value of PET with (18)F-FDG of the cervical cord in patients with CSM, paying attention to prognostic aspects and the potential role of inflammatory processes in the acute phase of the disease.",
keywords = "Cervical Vertebrae, Fluorodeoxyglucose F18, Humans, Magnetic Resonance Imaging, Positron-Emission Tomography, Spinal Cord Diseases, Spondylosis",
author = "Eicker, {Sven O} and Karl-Josef Langen and Norbert Galldiks and Gabriele Stoffels and J{\"o}rg Herdmann and Hans-Jakob Steiger and Floeth, {Frank W}",
year = "2013",
month = jul,
doi = "10.3171/2013.3.FOCUS1379",
language = "English",
volume = "35",
pages = "E2",
journal = "NEUROSURG FOCUS",
issn = "1092-0684",
publisher = "American Association of Neurological Surgeons",
number = "1",

}

RIS

TY - JOUR

T1 - Clinical value of 2-deoxy-[18F]fluoro-D-glucose positron emission tomography in patients with cervical spondylotic myelopathy

AU - Eicker, Sven O

AU - Langen, Karl-Josef

AU - Galldiks, Norbert

AU - Stoffels, Gabriele

AU - Herdmann, Jörg

AU - Steiger, Hans-Jakob

AU - Floeth, Frank W

PY - 2013/7

Y1 - 2013/7

N2 - Cervical spondylotic myelopathy (CSM) is one of the most common spinal cord disorders in the elderly. It is usually diagnosed by MRI, but in a significant number of patients the clinical course of CSM does not correlate with the extent of the spinal cord compression. Recent studies have suggested that a distinct metabolic pattern of the cervical cord, as assessed by PET with 2-deoxy-[(18)F]fluoro-D-glucose ((18)F-FDG) may predict a patient's clinical outcome after decompressive surgery for cervical spine stenosis. The authors provide an overview of the recent literature regarding the value of PET with (18)F-FDG of the cervical cord in patients with CSM, paying attention to prognostic aspects and the potential role of inflammatory processes in the acute phase of the disease.

AB - Cervical spondylotic myelopathy (CSM) is one of the most common spinal cord disorders in the elderly. It is usually diagnosed by MRI, but in a significant number of patients the clinical course of CSM does not correlate with the extent of the spinal cord compression. Recent studies have suggested that a distinct metabolic pattern of the cervical cord, as assessed by PET with 2-deoxy-[(18)F]fluoro-D-glucose ((18)F-FDG) may predict a patient's clinical outcome after decompressive surgery for cervical spine stenosis. The authors provide an overview of the recent literature regarding the value of PET with (18)F-FDG of the cervical cord in patients with CSM, paying attention to prognostic aspects and the potential role of inflammatory processes in the acute phase of the disease.

KW - Cervical Vertebrae

KW - Fluorodeoxyglucose F18

KW - Humans

KW - Magnetic Resonance Imaging

KW - Positron-Emission Tomography

KW - Spinal Cord Diseases

KW - Spondylosis

U2 - 10.3171/2013.3.FOCUS1379

DO - 10.3171/2013.3.FOCUS1379

M3 - SCORING: Journal article

C2 - 23815247

VL - 35

SP - E2

JO - NEUROSURG FOCUS

JF - NEUROSURG FOCUS

SN - 1092-0684

IS - 1

ER -